Skip to main content

Anesthesia, General

37
Pipeline Programs
9
Companies
7
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
12
0
24
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

9 companies ranked by most advanced pipeline stage

Pfizer
PfizerNEW YORK, NY
1 program
1
SedlinePhase 41 trial
Active Trials
NCT00938782Completed67Est. Jun 2012
MSD
MSDIreland - Ballydine
18 programs
6
12
RocuroniumPhase 3
SugammadexPhase 3
SugammadexPhase 3
SugammadexPhase 3
SugammadexPhase 3
+13 more programs
Sharp Therapeutics
Sharp TherapeuticsPA - Pittsburgh
18 programs
6
12
RocuroniumPhase 3
SugammadexPhase 3
SugammadexPhase 3
SugammadexPhase 3
SugammadexPhase 3
+13 more programs
Abbott
AbbottABBOTT PARK, IL
2 programs
Clinical Practice of Inhalation Anesthesia With Sevoflurane in ChinaN/A1 trial
Estimate the Behavior of Chinese Anesthesiologists Practicing General Anesthesia With SevofluraneN/A1 trial
Active Trials
NCT01715857Completed4,100Est. Jul 2013
NCT01199471Completed4,000Est. Nov 2010
Medtronic
MedtronicNJ - Phillipsburg
1 program
BIS deviceN/A1 trial
Active Trials
NCT03553953Completed98Est. Aug 2020
AbbVie
AbbVieNORTH CHICAGO, IL
1 program
Clinical Practice of Inhalation Anesthesia With Sevoflurane in ChinaN/A
GE HealthCare
1 program
Monitoring of frontal electrical muscle activityN/A1 trial
Active Trials
NCT03366662Withdrawn0Est. Dec 2018
Medasense Biometrics
Medasense BiometricsIsrael - Ramat Gan
1 program
PMD-200N/A1 trial
Active Trials
NCT03452163Terminated3Est. Nov 2019
Stryker
StrykerCA - San Jose
1 program
SNAP monitor; Bispectral Index MonitorN/A1 trial
Active Trials
NCT00829803Completed40Est. Jan 2011

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
PfizerSedline
MedtronicBIS device
Medasense BiometricsPMD-200
GE HealthCareMonitoring of frontal electrical muscle activity
AbbottClinical Practice of Inhalation Anesthesia With Sevoflurane in China
AbbottEstimate the Behavior of Chinese Anesthesiologists Practicing General Anesthesia With Sevoflurane
StrykerSNAP monitor; Bispectral Index Monitor

Clinical Trials (7)

Total enrollment: 8,308 patients across 7 trials

NCT00938782PfizerSedline

Using the SEDLine for the Titration of Sevoflurane in Elderly Patients Recovery Using the SEDLine TM for the Titration of Sevoflurane in Elderly Patients Undergoing Non-Cardiac Surgery After Beta-Adrenergic Blockade

Start: Jul 2006Est. completion: Jun 201267 patients
Phase 4Completed
NCT03553953MedtronicBIS device

Characterization of Artifacts in the BIS™ EEG Signals in General Anesthesia Patients in Operating Room

Start: Aug 2018Est. completion: Aug 202098 patients
N/ACompleted
NCT03452163Medasense BiometricsPMD-200

Performance Assessment of the PMD-200 in Subjects at Neurointensive Care Unit

Start: Mar 2018Est. completion: Nov 20193 patients
N/ATerminated
NCT03366662GE HealthCareMonitoring of frontal electrical muscle activity

The Effect of Frontal Electromyogram (F-EMG) Activity on the Entropy Index Behavior During General Anesthesia

Start: Dec 2017Est. completion: Dec 20180
N/AWithdrawn
NCT01715857AbbottClinical Practice of Inhalation Anesthesia With Sevoflurane in China

Clinical Practice of Inhalation Anesthesia With Sevoflurane in China

Start: Jul 2012Est. completion: Jul 20134,100 patients
N/ACompleted
NCT01199471AbbottEstimate the Behavior of Chinese Anesthesiologists Practicing General Anesthesia With Sevoflurane

Estimate the Behavior of Chinese Anesthesiologists Practicing General Anesthesia With Sevoflurane

Start: Sep 2010Est. completion: Nov 20104,000 patients
N/ACompleted
NCT00829803StrykerSNAP monitor; Bispectral Index Monitor

A Study to Assess Indices of SNAP vs VISTA on Surgical Patients Undergoing General Anesthesia

Start: Feb 2009Est. completion: Jan 201140 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

24 late-stage (Phase 3) programs, potential near-term approvals
9 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.